Local and systemic responses to SARS-CoV-2 infection in children and adultsMasahiro Yoshida, Fernando J. Calero‐Nieto, Kerstin B. Meyer et al.|Nature|2021Cited by 357
Distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumoniaNikolay S. Markov, Helen K. Donnelly, Ziyou Ren et al.|Nature Immunology|2024Cited by 16
Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumoniaRoxane Rohani, Sydney M. Hyder, Marc H. Scheetz et al.|Journal of Antimicrobial Chemotherapy|2022Cited by 4
Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis–Related Interstitial Lung Disease (Scleroderma Lung Study <scp>III</scp> ): An Investigator‐Initiated, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 TrialDinesh Khanna, Cathie Spino, Donald P. Tashkin et al.|ACR Open Rheumatology|2025Cited by 3